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Abstract 
The Vaccinia-Related Kinases (VRKs) are highly conserved throughout the animal 
kingdom and phosphorylate several chromatin proteins and transcription factors. In early 
Caenorhabditis elegans embryos, VRK-1 is required for proper nuclear envelope formation. 
In this work we present the first investigation of the developmental role of VRKs by means of 
a novel C. elegans vrk-1 mutant allele. We found that VRK-1 is essential in hermaphrodites 
for formation of the vulva, uterus, utse, and for development and maintenance of the somatic 
gonad and thus the germ line. VRK-1 regulates anchor cell polarity and the timing of anchor 
cell invasion through the basement membranes separating vulval and somatic gonadal cells 
during the L3 larval stage. VRK-1 is also required for proper specification and proliferation of 
uterine cells and sex myoblasts. Expression of the Fibroblast Growth Factor-like protein 
EGL-17 and its receptor EGL-15 is reduced in vrk-1 mutants, suggesting that VRK-1 might 
act at least partially through activation of FGF signaling. Expression of a translational VRK-
1::GFP fusion protein in the ventral nerve cord and vulva precursor cells restores vulva and 
uterus formation, suggesting both cell autonomous and non-autonomous roles of VRK-1.  
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Introduction 
Organ development requires sophisticated temporal and spatial control of gene 
expression and cell signaling to achieve the proper balance between cell proliferation and 
specification. The nematode Caenorhabditis elegans makes an excellent model organism for 
studying determination of cell fates and pattern formation during development. For instance, 
formation of the egg laying organs involves precisely orchestrating several conserved 
signaling cascades, such as the receptor tyrosine kinase (RTK)/Ras GTPase/MAPK, Notch 
and Wnt pathways (Sternberg, 2005). 
Post-embryonic development of C. elegans occurs in 4 larval stages, L1-L4, each 
separated by a molting period. In hermaphrodites, formation of the somatic reproductive 
organs, the vulva, uterus and gonads, starts during the L1 larval stage and continues through 
L4 until adulthood (Kimble and Hirsh, 1979; Sulston and Horvitz, 1977). During L1 and L2 
larval stages, 6 of the 11 ventrally located epidermal Pn.p cells are specified as vulva 
precursor cells (VPCs) by LET-60 (Ras) and Wnt signaling acting on the Hox gene lin-39. 
During L3 larval stage, 3 central VPCs (P5.p-P7.p) receive an inductive signal from the 
anchor cell (AC), a specialized gonadal cell (Hill and Sternberg, 1992; Kimble, 1981). The 
AC expresses and secretes the epidermal growth factor (EGF)-like ligand LIN-3 that activates 
the EGF receptor LET-23 in the underlying VPCs. P6.p receives the highest level of LIN-3 
and takes on a 1º fate, characterized by activation of the LET-60 signaling cascade (Sternberg 
and Horvitz, 1986). P6.p produces multiple ligands, such as DSL-1, LAG-2 and APX-1 (Chen 
and Greenwald, 2004; Shaye and Greenwald, 2002), which activate the LIN-12 (Notch) 
signaling pathway in the flanking P5.p and P7.p. (Sternberg, 1988) and downregulate LET-60 
signaling (Berset et al., 2001; Yoo et al., 2004). This results in the specification of a 2º fate of 
P5.p and P7.p (Sternberg, 1988; Yoo et al., 2004). The remaining 3 VPCs (P3.p, P4.p and 
P8.p) adopt a 3º fate and thus fuse with the syncytial epidermis hyp7. P5.p, P6.p and P7.p 
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undergo three rounds of division during the L3 and L4 larval stages to generate 22 vulval cells 
of seven different cell types. The vulval cells invaginate and undergo homotypic fusion to 
form seven distinct toroids. These toroids connect to the uterus, and evert as the 
hermaphrodite molts into adulthood (Sharma-Kishore et al., 1999). Formation of a connection 
between the vulva and the uterus is initiated in early L3 larval stage. The AC invades the 
basement membrane separating the gonad from the underlying developing vulva and attaches 
to two of the granddaughters of the central VPC, P6.pap and P6.ppa (Sherwood and 
Sternberg, 2003). The AC will stay at this position until the L4 larval stage when it fuses with 
8 π cells of the uterus and laterally attaches to seam cells to form the utse syncytium 
(Newman et al., 1996). Invasion of the AC is initiated by an invasion cue emitted by the 1º 
fated vulva cells (Sherwood and Sternberg, 2003). This cue provides guidance to the AC for 
correct spatial and temporal invasion of the basement membrane, but its identity remains 
unknown. In addition, secretion of UNC-6 (Netrin) from the ventral nerve cord (VNC) is 
important for AC invasion (Ziel et al., 2009). An AC autonomous signaling cascade has been 
discovered, of which several important transducers have been characterized. fos-1 encodes 
two isoforms of a basic region-leucine zipper transcription factor, FOS-1A and FOS-1B. Only 
FOS-1A activity is required for basement membrane removal and AC invasion (Sherwood et 
al., 2005). Known FOS-1A targets include CDH-3, a member of the cadherin superfamily, 
ZMP-1, a matrix metalloproteinase and EGL-43, a zinc finger protein (Hwang et al., 2007; 
Rimann and Hajnal, 2007; Sherwood et al., 2005). Simultaneous with the development of the 
vulva, a uterus lumen is formed that is flanked distally at each side by a spermatheca and 
gonadal arm. The gonad is a tube-shaped organ that starts at the spermatheca and extends 
towards the head or the tail end in L2/L3 larval stage (Kimble and Hirsh, 1979). The gonad 
makes a loop before reaching head or tail end and extends back towards the center of the 
animal, where both gonadal arms meet. 
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The Vaccinia-Related Kinase (VRK) family of proteins, an early branch from the 
casein kinase I family, is present in all metazoan kinomes (Klerkx et al., 2009; Nichols and 
Traktman, 2004). C. elegans and Drosophila have a single ortholog whilst the genomes of 
vertebrates contain 3 different VRK genes, VRK1-3. Human VRK1 phosphorylates several 
well-known transcription factors, such as tumor suppressor p53 (Lopez-Borges and Lazo, 
2000), c-Jun (Sevilla et al., 2004a) and ATF2 (Sevilla et al., 2004b). Alteration of VRK1 
activity prevents proper cell cycle progression (Valbuena et al., 2008) and has been linked to 
cancers (Santos et al., 2006). VRK3 acts negatively on ERK signaling through activation of 
VHR phosphatase (Kang and Kim, 2006). Purification of an activity that phosphorylates the 
tail of histone H2A led to the discovery of Drosophila Nucleosomal Histone Kinase-1 (NHK-
1), the fruit fly homolog of VRK (Aihara et al., 2004). Finally, biochemical studies and 
analysis of early C. elegans embryogenesis have identified the small chromatin associated 
protein BAF as a phosphorylation substrate for VRK-1 (Gorjanacz et al., 2007; Nichols et al., 
2006). The nature and diversity of identified VRK substrates suggest that this family of 
protein kinases may play important roles in several developmental processes. Indeed, nhk-1 
mutations disrupt proper meiosis in Drosophila, which at the same time has prevented 
elucidation of phenotypes later in development (Cullen et al., 2005; Ivanovska et al., 2005). 
We have previously described a role for VRK-1 in nuclear envelope formation in 
early, fast-dividing C. elegans embryos (Gorjanacz et al., 2007). To elucidate the function of 
VRK-1 in post-embryonic development we have characterized a vrk-1 mutant allele and 
found defects in formation of the reproductive organs. Our analysis has shown that VRK-1 is 
essential for formation of a normal vulva, uterus, and utse, and for development and 
maintenance of the somatic gonad. Mutation of vrk-1 impinges on FGF signaling, which may 
partly explain the defects in vulval and uterine development. 
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Materials and methods 
 
Strains and alleles  
C. elegans nematode strains were cultured and handled under standard conditions (Stiernagle, 
2006) at 20°C. We used strain N2 (Bristol) as wild-type reference. Other alleles and 
transgenes used in this study: AH142 zhIs4[pTB10 (Plip-1::nls::gfp)] (Berset et al., 2001), 
GS384 fos-1(ar105) (Seydoux et al., 1993), MT2124 let-60(n1046) (Ferguson and Horvitz, 
1985), NH2466 ayIs4[Pegl-17::nls::gfp] (Burdine et al., 1998), NH2447 ayIs2[Pegl-15::nls::gfp] 
(Harfe et al., 1998), NK409 qyls50[Pcdh-3::mCherry::moeABD] (Ziel et al., 2009), PD4810 
ccIs4810[Plmn-1::lmn-1::gfp] (Liu et al., 2000), PS3352 syIs50[Pcdh-3::gfp] (Inoue et al., 2002), 
PS3808 syIs80[Plin-11::nls::gfp] (Gupta and Sternberg, 2002), PS4308 syIs107[Plin-3::gfp] 
(Hwang and Sternberg, 2004), PS4384 syIs113[Post-1::ost-1/SPARC::gfp] (Hwang et al., 
2007), PS4411 syIs123[Pfos-1::yfp::fos-1A], (Sherwood et al., 2005), PS5443 [Pegl-43::nls::yfp] 
(Hwang et al., 2007), VB1497 ayIs4; rrf-3(pk1426); sid-1(qt2) (Tiensuu et al., 2005). BN3 
vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II was generated by backcrossing VC704 from the 
International C. elegans Gene Knockout Consortium to the wild-type N2 6 times. BN3 was 
further crossed with aforementioned strains (see Suppl. Table I). 
 
Microscopy 
Microscopy analysis including differential interference contrast (DIC) and fluorescent protein 
imaging was done mainly on a Leica SP2 confocal microscope with 100x 1.40 – 0.7 oil CS 
objective. Animals were mounted in a 5 µl drop of 10 mM levamisole on a 3% agarose pad, 
covered with a 24 mm x 24 mm coverslip, which was sealed with Vaseline. 
 
Software analysis and statistics 
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Images were captured using Leica Confocal Software LAS AF. ImageJ was used to measure 
fluorescent intensities of individual nuclei or cells in single focal sections. Statistical analysis 
was performed using Microsoft Excel. Equal adjustment of control, mutant and RNAi images 
was done using Adobe Photoshop. 
 
RNAi 
For RNA interference by feeding, clones were obtained from the library described by 
(Kamath and Ahringer, 2003). RNAi was achieved by feeding L4 staged animals for 24 hours 
at 20°C on bacterial lawns expressing double-stranded RNA for the targeted gene. The empty 
pPD129.36 L4440 feeding vector was used as control. F1 offspring were evaluated when 
reaching the correct stage.  
Knockdown of vrk-1 expression in vulva precursor cells was performed by tissue-specific 
expression of a vrk-1 RNA hairpin in VB1497 ayIs4; rrf-3(pk1426); sid-1(qt2) animals 
(Tiensuu et al., 2005). Plasmid pBN30 containing the lin-31 promoter upstream of a 791 bp 
vrk-1 exon 4 inverted repeat separated by intron 2 from the eat-2 gene was injected together 
with plasmid pRF4 rol-6 into the germ line of VB1497 young adults. Transgenic animals 
were identified based on the dominant Rol phenotype. 
 
Transgenesis 
A Pvrk-1::VRK-1::GFP construct was made by PCR amplification and stitch technique. 870 bp 
of genomic vrk-1 DNA upstream of the vrk-1 start codon was used as promoter sequence. The 
vrk-1 stop codon was replaced by GFP with a stop codon, followed by 1494 bp of vrk-1 
3’UTR sequence. The construct was introduced into the pSTW destination vector containing 
an unc-119 rescuing allele by Gateway cloning. The final plasmid was bombarded into unc-
119(ed3) worms, which generated two integrated lines, YL255 vrIs13 and YL262 vrIs15. Of 
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these, vrIs13 shows the strongest expression of VRK-1::GFP and was used for the 
experiments shown in Figs. 3, 6 and Suppl. Figs. 1, 2. vrIs15 was used for the experiments 
shown in Suppl. Fig. 3. 
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Results 
 
Mutation of vrk-1 interferes with vulval development 
To investigate the role of vrk-1 in postembryonic development we characterized a 
novel vrk-1 allele, ok1181, isolated by the International C. elegans Gene Knockout 
Consortium. The wild-type vrk-1 gene encodes a 67 kDa protein of 610 amino acids that has 
an N-terminal serine/threonine protein kinase domain and a C-terminal basic-acidic-basic 
(BAB) motif (Aihara et al., 2004; Klerkx et al., 2009). The ok1181 allele deletes 1139 bp 
from the second intron to the fifth exon, corresponding to ~30% of the protein kinase domain 
and the entire BAB motif. To determine whether the C-terminus of the VRK-1 protein is 
expressed in ok1181 mutants, we cloned the ok1181 mRNA by RT-PCR. This revealed that 
exon 2 is spliced to exon 6 in ok1181 mutants, thus skipping exon 5, but maintaining the 
reading frame (Fig. 1A). Conceptual translation of the ok1181 mRNA predicts a protein of 31 
kDa. However, we have not been able to detect any truncated VRK-1 protein by Western blot 
analysis of ok1181 extracts (data not shown), suggesting that the amount of mutant VRK-1 
protein expressed in ok1181 animals is below the detection level of our antibodies. 
Depletion of VRK-1 by RNAi leads to early embryonic death (Gorjanacz et al., 2007; 
Piano et al., 2002). Homozygous vrk-1(ok1181) animals produced by heterozygous vrk-
1(ok1181) hermaphrodites (denoted hereafter as vrk-1 mutants) overcome this lethality 
presumably by maternal contribution and show no apparent defects until early L3 larval stage. 
The gonads in vrk-1 mutants extend and loop back but do not reach the fully extended stage 
(Fig. 1B). The germ line contains fewer and larger, abnormal nuclei (Fig. 1B). Upon reaching 
adulthood, the gonads are devoid of germ nuclei, resulting in 100% sterility (data not shown). 
In addition, vrk-1 mutants do not form a uterus lumen at the L4 stage (n>100) nor a uterus 
seam syncytium (utse) (Fig. 1C). When reaching adulthood, 75% (n>200) of the vrk-1 
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mutants have a strong protruding vulva (Pvl) phenotype (Fig. 1D), presumably as 
consequence of lacking utse formation (Hanna-Rose and Han, 1999). 
 
VRK-1 regulates timing of anchor cell invasion 
As the vrk-1 mutants show a highly penetrant Pvl phenotype, we sought to investigate 
vulval development. To evaluate vulval induction we generated a vrk-1 mutant strain 
expressing GFP in the anchor cell (AC) under control of the lin-3 promoter. We observed no 
change in relative expression of the LIN-3 inductive signal in the AC (n=15) (Fig. 2A), 
suggesting that vulval induction is normal in vrk-1 mutants. Furthermore, we lineaged the 
VPC divisions in vrk-1 mutants and found no defects in the first two rounds of division (n=10; 
data not shown). At late L4 however, 33% of vrk-1 mutants were missing from 1 to 4 vulva 
cells (n=18; data not shown). We did not investigate if the reduced cell number was the 
consequence of underproliferation or cell death, but since this relative mild phenotype was 
less frequent than the Pvl phenotype, it cannot be the cause of the latter. We conclude that the 
AC induces the vulva normally and that the vulval lineage does not deviate dramatically from 
the wild-type. We next went on to investigate the behavior of the AC. In wild-type animals, 
AC invasion is always completed by the P6.p 4-cell stage in late L3 (Sherwood and 
Sternberg, 2003). The basement membranes can be seen by differential interference contrast 
(DIC) microscopy but for better visualization we generated a strain expressing OST-
1/SPARC::GFP in the vrk-1 mutant background. SPARC is an extracellular matrix-associated 
protein that is located on basement membranes (Fitzgerald and Schwarzbauer, 1998). As 
expected, control animals showed an interruption of the basement membranes right above the 
central vulva cells in late L3 (Fig. 2B). In 86% of the vrk-1 mutants, however, the AC had not 
breached the basement membranes at this stage (n=29)(Fig. 2B). This AC invasion defect is a 
delay, as by the 8-cell stage in L4 all vrk-1 mutants had breached basement membranes (data 
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not shown). Prior to invasion the AC is polarized, at least partially controlled by UNC-6 
(Netrin) secreted from the VNC (Ziel et al., 2009). To investigate if AC polarization also 
depends on vrk-1, we analyzed the localization of the actin-binding protein, moeABD fused to 
mCherry. In control animals, mCherry::moeABD accumulated at the basal side of the AC, 
facing the basement membranes (Fig. 2C, n=50). Basal mCherry::moeABD accumulation was 
also observed in vrk-1 mutants, but 42% of the mutants had additional apically localized 
mCherry::moeABD foci (Fig. 2C, n=48). Thus, both AC polarity and timing of invasion are 
affected by the vrk-1 mutation. 
Mutation of fos-1 leads to a strong inhibition of AC invasion (Sherwood et al., 2005). 
We therefore investigated if mutation of vrk-1 affected expression of FOS-1 and its 
downstream targets CDH-3 and EGL-43. Compared to control animals, we did not detect 
changes in expression of any of these genes in vrk-1 mutants (Suppl. Fig. 1). We do not rule 
out the possibility that VRK-1 functions in fos-1 signaling, but our data indicate that VRK-1 
regulates AC invasion independently of this pathway. 
 
Postembryonic expression of VRK-1 
In C. elegans, many genes are part of operons, which are groups of genes expressed 
from a common promoter (Blumenthal, 2005). vrk-1 is the last gene in an operon of eight 
genes. However, significant numbers of operon genes are thought to also have an internal 
promoter sequence (Huang et al., 2007). To analyze this latter possibility, we generated 
transgenic strains using 870 bp directly upstream of the vrk-1 translational start codon, 
followed by the vrk-1 ORF fused in-frame with GFP and terminating with 1.4 kb of vrk-1 
3’UTR. We obtained two stably expressing, integrated lines, showing very similar expression 
patterns. Nuclear expression of VRK-1::GFP was observed in neurons and hypodermal cells 
in the head, VNC and tail of C. elegans larvae (Suppl. Fig. 2). We also detected strong 
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expression in all VPCs (Fig. 3A; Suppl. Fig. 2; n>50). At the L3 larval stage expression was 
highest in the primary fated vulva cell P6.p and its descendants (Fig. 3A; n=28). At L4 stage, 
VRK-1::GFP was expressed at equal levels in all 22 nuclei (Fig. 3C, Suppl. Figs. 2, 3). 
During division of VPCs, VRK-1::GFP showed an identical dynamic localization as 
previously reported in early embryos (Gorjanacz et al., 2007). VRK-1::GFP was nuclear 
during interphase but relocated to the nuclear periphery immediately before cell division (Fig. 
3A, 4-cell stage late). During mitosis the protein was bound to chromatin (data not shown; see 
(Gorjanacz et al., 2007)). One of the two transgenic strains showed additional but very weak 
VRK-1::GFP expression in some uterine cells (data not shown). We have never observed 
expression in the AC with any of the two strains. Consistent with our results, two other 
laboratories have generated strains expressing GFP driven by the sequence directly upstream 
of the vrk-1 ORF and also reported expression in the vulva (McKay et al., 2003; Vazquez-
Manrique et al., 2007). Although immunofluorescence experiments using α-VRK-1 
antibodies revealed that endogenous VRK-1 is expressed in the germ line and in early 
embryos ((Gorjanacz et al., 2007); data not shown), none of the two VRK-1::GFP strains 
showed signal in the germ line. However, many transgenes in C. elegans are silenced in the 
germ line, which likely affects the Pvrk-1::VRK-1::GFP transgene (Kelly et al., 1997). 
To investigate if the VRK-1::GFP expression pattern reflects the site of action of 
endogenous VRK-1, we performed tissue-specific knockdown and rescue experiments. We 
rationalized that if VRK-1 acts in the VPCs to regulate AC behavior and utse formation, 
depletion of VRK-1 specifically from these cells should reproduce the Pvl phenotype 
observed in vrk-1 mutants. Following the approach of Tiensuu and colleagues, we used the 
lin-31 promoter to drive expression of a vrk-1 RNA hairpin in VPCs of animals with 
sensitized RNAi cellular response (caused by the rrf-3(pk1426) allele) but incapable of 
systemic RNAi (caused by the sid-1(qt2) allele) (Tiensuu et al., 2005). The lin-31 promoter is 
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active in Pn.p cells, including VPCs, but not in the gonad (Tan et al., 1998). Observing two 
independent mosaic transgenic lines, we found that 19.7% of the transformed animals 
developed Pvl and/or Egl phenotypes within 48h of reaching the adult stage (Fig. 1D; n=212). 
This represents a statistical difference when compared to non-transformed rrf-3(pk1426); sid-
1(qt2) animals, of which only 4.0% developed an Egl phenotype within 48h of reaching the 
adult stage (n=101, p<0.001 by Chi-square Test). In contrast to vrk-1 mutants, but consistent 
with the cell-specificity of the lin-31 promoter, the transgenic animals were fertile. 
We next tested if expression of VRK-1::GFP can rescue the defects observed in the 
vrk-1 mutant. Indeed, expression of VRK-1::GFP in the vulva cells rescued the AC invasion 
delay (100%, n=12, p=2.3x10-7 by Fisher’s Exact Test) (Fig. 3B, Suppl. Fig. 3A) and re-
established formation of the uterine lumen and utse (100%, n=29, p=3.0x10-22 by Fisher’s 
Exact Test) (Fig. 3C; Suppl. Fig. 3B). In adult vrk-1 mutants, VRK-1::GFP expression 
reduced the Pvl phenotype to 24% (n=50, p=2.4x10-13 by Fisher’s Exact Test), whilst, as 
expected, the germline defects were not rescued. Importantly, these experiments demonstrate 
the functionality of the fusion protein and suggest that sequences immediately upstream and 
downstream of the vrk-1 ORF direct VRK-1::GFP expression in a manner reminiscent of 
endogenous vrk-1. To complement our observation that FOS-1 expression is vrk-1-
independent (Suppl. Fig. 1), we investigated if fos-1 is required for VRK-1 expression. 
Similarly to vrk-1 mutants, disruption of FOS-1 activity prevents utse formation (Sherwood et 
al., 2005); however, we did not observe any changes in VRK-1::GFP expression in vulva cells 
in fos-1 mutants (Suppl. Fig. 1). 
 
Defects in uterine precursor cells  
We have previously described an essential role for VRK-1 in nuclear envelope 
formation in rapidly dividing C. elegans embryos (Gorjanacz et al., 2007). The defects in 
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vulval and uterine formation could therefore be related to an abnormal nuclear structure in 
post-mitotic vulva and uterine cells. To investigate in detail the morphology of the nuclear 
envelope, we analyzed the localization of LMN-1::GFP in vrk-1 mutants. LMN-1 (Lamin) is a 
component of the nuclear envelope, underlying the nuclear membrane and providing stability 
to the nuclear envelope (Liu et al., 2000). In early embryos depleted of VRK-1 by RNAi, 
LMN-1 does not localize to the nuclear rim and nuclear morphology is disrupted (Gorjanacz 
et al., 2007). However, LMN-1::GFP showed a smooth, uniform nuclear envelope staining in 
the vulva cells of both control (n=10) and vrk-1 mutant (n=18) animals, suggesting that vulva 
cell nuclei are assembled correctly in the absence of wild-type VRK-1 activity (Fig. 4A, 
arrowheads). In contrast, the uterine cells displayed severe nuclear envelope defects in all vrk-
1 mutant animals (Fig. 4A, arrows). The abnormal LMN-1::GFP distribution in the uterine 
cells prompted us to have a closer look at the development of the uterus. We sought to 
investigate whether the π cells, specialized uterine cells some of whose progeny will fuse with 
the AC to form the utse syncytium, are born and have the right cell fate (Newman et al., 
1996). In wild-type animals, LIN-11, a LIM homeodomain transcription factor, was expressed 
in all 12 (6 left and 6 right) π cells (Fig. 4B) (Newman et al., 1999). In vrk-1 mutants, 75% 
(n=12) of the animals completely lacked expression of LIN-11 in uterine cells (Fig. 4B) while 
the remaining 25% had a reduced number of Plin-11::GFP positive cells (data not shown). Thus, 
VRK-1 is necessary for specification of uterine π cells. Importantly, uterine defects in vrk-1 
mutants were rescued completely by expression of VRK-1::GFP specifically in vulva cells 
(Fig. 3C), arguing that VRK-1 expression is not required in uterine cells and that VRK-1 acts 
cell non-autonomously.  
 
VRK-1 regulates EGL-17/Fibroblast Growth Factor signaling 
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Several interconnected signaling pathways are crucial for proper vulval and uterine 
formation (Sternberg, 2005). To investigate involvement of VRK-1 in receptor tyrosine 
kinase (RTK)/Ras/MAP kinase (MAPK) signaling, we measured the activity of the egl-17 
promoter. EGL-17, a fibroblast growth factor (FGF)-like protein, is expressed in P6.p and its 
descendants (Burdine et al., 1998). Both in control and vrk-1 animals, Pegl-17::GFP expression 
was higher in P6.p descendants than in neighboring P5.p and P7.p descendants (Fig. 5B). By 
measuring fluorescent intensity in P6.p descendants we found that vrk-1 mutants (n=61) had a 
4.6-fold reduction in Pegl-17::GFP expression compared to control animals (n=72; p<0.001 by 
Student’s t-test) (Fig. 5B). To confirm that the reduced Pegl-17::GFP expression reflected a 
decrease in endogenous EGL-17 activity, we investigated the behavior of the sex myoblasts 
(SMs) in vrk-1 mutants. During L2 larval stage two SMs, SML and SMR, migrate from the 
posterior part of the body to the centre close to P6.p to establish the vulval and uterine 
muscles (Sulston and Horvitz, 1977). The SMs divide three times to generate eight vulval and 
eight uterine muscle cells. The behavior of the SMs depends on EGL-17 and its receptor 
EGL-15, an FGF receptor tyrosine kinase, which activates LET-60 (Ras) in the SMs (Burdine 
et al., 1998; DeVore et al., 1995). Monitoring a Pegl-15::GFP reporter strain revealed that vrk-1 
mutants (n=68) expressed 45% less GFP in SML and SMR as compared to control animals 
(n=84; p<0.001 by Student’s t-test) (Fig. 5C). SMs migrated normally but failed to proliferate 
properly. During early-mid L3 stage the SMs divided once in both control animals (n=20) and 
vrk-1 mutants (n=11) but nuclear morphology was abnormal in SM daughter cells in vrk-1 
mutants and cell division had ceased (Suppl. Fig. 4, n=14). In conclusion, two components of 
EGL-17/FGF signaling both show significantly lower expression in the vrk-1 mutant. 
Hyperactivation of Ras signaling by the let-60(n1046) gain-of-function allele causes 
formation of ectopic multivulvae (Muv; (Ferguson and Horvitz, 1985)) while inhibition of 
LET-60 signaling reduces EGL-17 expression (Cui and Han, 2003). Since mutation of vrk-1 
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reduced expression of Pegl-17::GFP we investigated if vrk-1(ok1181) was able to suppress the 
let-60(n1046) Muv phenotype. However, let-60(n1046); vrk-1(ok1181) double mutants had a 
slightly increased frequency of Muv animals (Suppl. Table II). This suggests that VRK-1 
either acts upstream of LET-60 or that VRK-1’s effect on EGL-17/EGL-15 signaling is 
independent of LET-60. LET-60-independent regulation of the EGL-17/EGL-15 pathway has 
been proposed previously (DeVore et al., 1995; Sundaram, 2006). 
Specification of the 2º cell fate in P5.p and P7.p involves both a graded LIN-3 signal 
from the AC and lateral induction via ligands produced by the 1º cell-fated P6.p (see 
Introduction). The observation that vrk-1 mutants had a reduced expression of Pegl-17::GFP, a 
commonly used marker for the 1º cell fate, prompted us to investigate commitment of P5.p 
and P7.p to the 2º cell fate. Expression of the phosphatase LIP-1 in P5.p and P7.p and their 
descendants requires activated LIN-12 (Notch) signaling while only very weak expression is 
detected in the P6.p lineage (Berset et al., 2001). The vrk-1 mutation did not cause detectable 
changes in expression of Plip-1::GFP (Fig. 5C, n=17 control and 14 vrk-1 animals), suggesting 
that P6.p in the absence of VRK-1 still expresses sufficient inducers of LIN-12 and that VRK-
1 is not required in P5.p and P7.p to regulate LIN-12. 
 
VRK-1 as a sumoylation target during vulval development 
Understanding VRK-1’s role in vulval and uterine development requires not only the 
identification of the signaling pathways affected by VRK-1 but also a characterization of how 
VRK-1 is regulated. To identify genes regulating VRK-1 expression in VPCs, we analyzed by 
RNAi 13 candidates with reported expression and/or function in vulval formation. By this 
approach we have identified smo-1 as a negative regulator of VRK-1 expression. Depletion of 
SMO-1 by RNAi resulted as expected in high embryonic lethality ((Kamath et al., 2003); data 
not shown). Compared to control RNAi animals, 88% of larvae surviving the smo-1 RNAi 
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showed a dramatic increase in expression of VRK-1::GFP (Fig. 6A, n=24). smo-1 encodes the 
small ubiquitin-related modifier protein SUMO and is required for morphogenesis of the 
gonad, vulva and uterus (Broday et al., 2004). Through processes similar to ubiquitination, 
sumoylation involves E1, E2, and E3 enzyme activities. Since interfering with the activities of 
E1-E3 blocks sumoylation and thereby phenocopies depletion of SUMO we next analyzed the 
expression of VRK-1::GFP in larvae depleted for UBA-2, a subunit of the SUMO activating 
E1 enzyme (Poulin et al., 2005). Similar to the observation in smo-1(RNAi) animals, depletion 
of UBA-2 led to an increase in expression of VRK-1::GFP in 85% of the animals observed 
(Fig. 6B, n=20). Together, these findings demonstrate an involvement of sumoylation in 
VRK-1 protein synthesis and/or degradation. However, despite several attempts, we have 
been unable to generate α-VRK-1 antibodies of sufficient quality to investigate if VRK-1 
itself is sumoylated. 
 
 
 
 
Discussion 
Studies on formation of the C. elegans vulva have contributed significantly to 
understanding cell behavior, cell-cell interactions and signaling pathways in organogenesis. In 
this study we have demonstrated that the Vaccinia-Related Kinase VRK-1 plays an essential 
role in development of the C. elegans egg-laying organs. Animals carrying a vrk-1 mutant 
allele that deletes approximately half of the ORF displayed defects in anchor cell (AC) 
invasion and formation of the vulva, utse and uterus, resulting in a strong protruding vulva 
(Pvl) phenotype. 
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VRK-1 regulates AC polarity and invasion 
The AC breached the basement membranes separating it from the epithelial vulva 
precursor cells (VPCs) significantly later in vrk-1 mutants. The transcription factor FOS-1A is 
a key regulator of AC invasion but an uncharacterized FOS-1A-independent pathway is also 
important (Sherwood and Sternberg, 2003). Our observation that neither FOS-1 itself nor 
FOS-1 targets CDH-3 and EGL-43 showed altered expression in vrk-1 mutants and that FOS-
1 was not required for VRK-1 expression, suggest that VRK-1 acts FOS-1-independently. AC 
invasion is regulated by an unknown cue from the VPCs (Sherwood and Sternberg, 2003) and 
by secretion of UNC-6 (Netrin) from the ventral nerve cord (VNC) (Ziel et al., 2009). UNC-6 
regulates polarized accumulation of its receptor UNC-40 and F-actin at the basal side of the 
AC (Ziel et al., 2009). While basal accumulation of F-actin was still observed in the AC of 
vrk-1 mutants, additional F-actin foci were induced apically, suggesting that proper AC 
apical-basal polarity is dependent on VRK-1. Future studies should address if VRK-1 
regulates AC polarity via UNC-6/UNC-40. The invasion cue emitted by the central vulva 
cells towards the AC to direct the breaching of the basement membranes has remained 
unknown but we postulate that VRK-1 could have a function in the emission of this cue. 
Sequences immediately upstream of the VRK-1 ORF induced expression of VRK-1::GFP in 
the VPCs and cells of the VNC, but not in the AC, yet the transgene rescued the AC invasion 
delay completely. In addition, depletion of VRK-1 specifically from VPCs phenocopied the 
vulval defects observed in vrk-1 mutants. This suggests that VRK-1 activity in the cells 
underlying the AC is necessary for proper temporal regulation of AC invasion (Fig. 6C). 
Given the implication of cell invasion across basement membranes in a multitude of 
biological processes, we speculate that VRKs may have widespread roles during animal 
development and disease conditions, including cancer metastasis (Santos et al., 2006; 
Sherwood, 2006). 
 19 
 
VRK-1 is required for specification and proliferation of uterine and muscle cells 
Downregulation of EGL-17 (FGF) and EGL-15 (FGFR) expression upon mutation of 
vrk-1 implies that VRK-1 is likely an activator of, or a signal transducer in this Receptor 
Tyrosine Kinase (RTK) pathway. This correlates with the observed upregulation of VRK-1 in 
the central 1º fated vulva cell and its progeny during L2/L3 larval stage and suggests an 
important role for VRK-1 in these cells. EGL-17 expression in VPCs is controlled by the 
LIN-39 Hox transcription factor, which in turn is positively regulated by Wnt and LET-60 
(Ras) signaling (Cui and Han, 2003; Sternberg, 2005). We found that VRK-1 does not appear 
to be required for hyperactivated LET-60 to induce multivulvae formation. Although this 
implies that VRK-1 is not an essential component of LET-60 signaling in ectopic VPCs, it 
does not exclude a role of VRK-1 in LET-60 signaling in P6.p and its descendants. Likewise, 
while inhibition of LET-60 signaling leads to a decrease in EGL-17 expression (Burdine et 
al., 1998), hyperactivation of LET-60 does not increase EGL-17 expression in P6.p (data not 
shown; (Berset et al., 2001)). During vulval formation, RTK signaling is also activated in the 
sex myoblasts (SMs) in response to secretion of EGL-17-from the central VPCs and the 
gonads (Burdine et al., 1998; DeVore et al., 1995; Thomas et al., 1990). Our observation that 
proliferation of SMs was impaired in vrk-1 mutants is likely to be caused at least partially by 
decreased EGL-17/EGL-15 signaling. Conversely, hyperactivation of EGL-15 prevents 
differentiation of SM descendants without affecting SM proliferation (Sasson and Stern, 
2004). Taken together, these observations suggest that FGF signaling has to be precisely 
controlled to achieve proper balance between proliferation and differentiation during 
development of C. elegans vulval and uterine muscles.  
Reduced VRK-1 activity led to failure of uterine π  cell specification. Absence of π 
cells implied that the utse structure at the junction between the vulva and the uterus was not 
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formed. Together, this provides an explanation for the observed Pvl phenotype in vrk-1 
mutants as when the vulva everts, the utse (Newman et al., 2000) and presumably also the 
vulval muscles are required for providing mechanical support to prevent abnormal eversion. 
Importantly, specific depletion of VRK-1 from VPCs was sufficient to induce the Pvl 
phenotype, whereas expression of VRK-1::GFP in the VPCs and VNC rescued utse and 
uterine development and suppressed the Pvl phenotype. Thus, similar to VRK-1’s role in AC 
invasion, the effect of vrk-1 mutation on π cells and SMs appears to be cell non-autonomous 
(Fig. 6C).  
 
Regulation of VRK-1 expression 
The rescuing capacity of the VRK-1::GFP transgene combined with tissue-specific 
RNAi experiments suggested that the behavior of the transgene reflected the expression 
pattern of endogenous vrk-1. Moreover, using essentially the same regulatory sequences 
upstream of the VRK-1 ORF to drive expression of GFP only also directed expression in the 
vulva (McKay et al., 2003; Vazquez-Manrique et al., 2007). While this does not exclude an 
important role of the upstream operon promoter in inducing VRK-1 expression in certain 
tissues and/or during certain developmental stages, these observations support the notion that 
many operons may carry functionally relevant internal promoters (Huang et al., 2007). 
Protein sumoylation, the conjugation of the small protein SUMO to a substrate, is a 
post-translational modification that typically affects the subcellular localization or protein 
stability of the substrate, thereby changing its biological activity (Geiss-Friedlander and 
Melchior, 2007). Inhibition of sumoylation by smo-1 or uba-2 RNAi caused a strong increase 
in expression of VRK-1::GFP. VRK-1 may either be a direct sumoylation substrate or 
negatively regulated by sumoylated proteins. Proteins involved in vulval and uterine 
formation that are known to be sumoylated are transcription factors LIN-1 (Leight et al., 
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2005) and LIN-11 (Broday et al., 2004). Sumoylation of LIN-11 is required for its function in 
π cell differentiation, and is thus essential for the formation of the utse (Broday et al., 2004). 
Sumoylation of the ETS transcription factor LIN-1 is essential for transcriptional repression 
of genes that promote vulval cell fates (Leight et al., 2005). Downregulation of LIN-1 or LIN-
11 by RNAi does not affect expression of VRK-1::GFP, indicating that these transcription 
factors do not regulate vrk-1 (data not shown). We conclude that VRK-1 expression is 
negatively affected by sumoylation but further work is required to determine if VRK-1 itself 
is sumoylated. Furthermore, our observations increase the number of proteins, which are both 
regulated by sumoylation and act in vulval and uterine development, strengthening the link 
between these processes. Interestingly, sumoylation of mammalian c-Fos reduces its activity 
(Bossis et al., 2005), opening the possibility that sumoylation may also influence FOS-1-
dependent processes in the C. elegans AC. 
 During early embryogenesis, VRK-1 regulates the localization of chromatin-binding 
protein BAF-1 in a cell cycle and phosphorylation-dependent manner (Gorjanacz et al., 2007). 
The vrk-1 mutant allele characterized in this work retains all kinase motifs but lacks most 
parts outside the kinase domain, presumably rendering the mutant protein unable to interact 
with some or all of its binding partners. Determination of whether VRK-1’s kinase activity is 
required for vulval and uterine development requires further studies. Drosophila and 
mammalian VRKs phosphorylate several transcription factors and affect chromatin 
modifications (Klerkx et al., 2009). So far, none of the C. elegans orthologs for these VRK 
substrates has been brought in relation to vulval or uterine development, nor AC invasion. 
However, future information about VRKs in C. elegans and other organisms will doubtlessly 
provide insight to the role of this emerging family of protein kinase in formation of C. elegans 
reproductive organs in particular and organ development in general.  
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Figure legends 
 
Fig. 1. vrk-1 mutants show defects in germline, uterine and vulval development. (A) 
Schematic representation of the vrk-1 gene. Purple: vrk-1 promoter used in this work; blue 
boxes: vrk-1 exons; light blue boxes: vrk-1 kinase domain; yellow box: BAB domain; shaded 
grey: 3’UTRs; red bar: region deleted in ok1181; dashed lines: mRNA splicing pattern. In 
ok1181 mRNA, exon 2 is spliced to exon 6. (B) Gonad arms of control and vrk-1 mutant late 
L4 larvae outlined in white. The vrk-1 mutant gonad is smaller and contains abnormally 
enlarged cells (arrowheads). Boxed regions are shown at higher magnification to the left. (C) 
At late L4, the control larva has developed vulval (V) and uterine (U) lumens and uterine-
seam cell connection (utse; arrowhead). The vrk-1 mutant has developed a vulval lumen, but 
the uterine lumen and the utse are missing. (D) Control adult animal shows a normally everted 
vulva whilst mutation of vrk-1 or RNAi-mediated depletion of VRK-1 specifically in vulva 
cells induces a protruding vulva (Pvl) phenotype (arrowheads). Scale bars, 10 µm. 
 
Fig. 2. Anchor cell invasion is impaired in vrk-1 mutants. (A) Vulval induction is normal in 
vrk-1 mutants as visualized by equal lin-3-driven expression of GFP in the AC of control and 
vrk-1 early L3 larvae. (B) In wild-type early L3 stage, at the P6.p 4-cell stage, the AC has 
invaded the basement membrane, as can be seen by DIC and discontinuous SPARC::GFP 
signal. In the vrk-1 mutant, the AC has not invaded yet. (C) F-actin, visualized by 
mCherry::moeABD expressed from the cdh-3 promoter, accumulates at the basal side of the 
AC in wild-type L3 stage (arrow). In the vrk-1 mutant, foci of F-actin accumulation are also 
observed apically (arrowhead). Scale bars, 5 µm 
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Fig. 3. VRK-1 is expressed in the ventral nerve cord and vulva cells. (A) Expression of VRK-
1::GFP from the vrk-1 promoter is observed in nuclei of ventral nerve cord cells 
(arrowheads), in all VPCs (1-cell stage) and is enriched in the descendants of the central P6.p 
(2-cell and 4-cell stages; brackets). At the onset of cell division, VRK-1::GFP relocates to the 
nuclear rim (4-cell stage late). (B, C) The AC invasion delay (B) and the absence of a uterine 
lumen and utse (C) in the vrk-1 mutant (left) is rescued by expression of VRK-1::GFP (right). 
Arrowheads denote AC position (B) and utse (C); U denotes uterine lumen. Scale bars, 5 µm. 
 
Fig. 4. VRK-1 is required for specification of uterine precursor cells. (A) In control and vrk-1 
mutant animals, vulva cells have a normal nuclear appearance visualized by expression of 
LMN-1::GFP (arrowheads). In contrast, nuclei of uterine precursor cells (arrows) have an 
aberrant structure in the vrk-1 mutant. (B) In the control animal, 6 π cells on each side of the 
body are visualized by expression of GFP from the lin-11 promoter (arrowhead points to π 
cells on one side). In most vrk-1 mutants, no GFP expressing cells are observed. Scale bars, 5 
µm. 
 
Fig. 5. VRK-1 stimulates FGF signaling. (A, B) The average fluorescent intensity of Pegl-
17::GFP in the descendents of P6.p (A) and of Pegl-15::GFP in the sex myoblasts at the 1-cell 
stage (B) is reduced in vrk-1 mutants as compared to control animals (p<0.001, Student’s t-
test). A.U. Arbitrary Units. (C) Expression of GFP driven by the lip-1 promoter in P5.p and 
P7.p, and to a lesser extent in P6.p, is similar in control and vrk-1 mutant animals. Scale bars, 
5 µm. 
 
Fig. 6. Sumoylation regulates VRK-1 expression. (A) Expression of VRK-1::GFP in smo-
1(RNAi) larvae is highly up-regulated as compared to control RNAi larvae. At microscope 
 29 
settings for which fluorescent intensity reached saturation in the smo-1(RNAi) larvae, the 
VRK-1::GFP fluorescent signal is barely detectable in the control. Insert shows an image of 
the same control animal acquired using higher microscope sensitivity (0.3x magnification 
relative to other panels). (B) Expression of VRK-1::GFP in larvae depleted for UBA-2 is up-
regulated as compared to control RNAi treatment. Scale bars, 5 µm. (C) Model of VRK-1’s 
role in vulval and uterine development. See Discussion for details. Pn.p, vulva precursor cells; 
VNC, ventral nerve cord cell; AC, anchor cell; π, uterine π cells; SM, sex myoblast. 
 
Suppl. Fig. 1. FOS-1 and its targets are expressed normally in vrk-1 mutants. Expression of 
Pfos-1a::FOS-1A::YFP (A), Pcdh-3::GFP (B) and Pegl-43::NLS::YFP (C) in the AC (arrowhead) is 
unaffected in vrk-1 mutants (n=16 (A); 19 (B); 10 (C)) as compared to control animals (n=13 
(A); 15 (B); 10 (C)). (D) Similarly, expression of Pvrk-1::VRK-1::GFP is independent of fos-1 
(n= 22 control animals; 10 fos-1(ar105) animals). Scale bars, 5 µm.  
 
Suppl. Fig. 2. Expression of Pvrk-1::VRK-1::GFP at the L4 larval stage in neurons and 
hypodermal cells in the head (left), tail (right) and ventral (down) area of the worm. Strong 
expression is observed in the developing vulva (insert). Scale bar, 40 µm.  
 
Suppl. Fig. 3. vrk-1 mutant phenotypes are rescued by low expression of VRK-1::GFP from 
the integrated transgene vrIs15. (A) In control animals (left), the AC has invaded the 
basement membrane by the P6.p 4-cell stage (arrowheads). In the vrk-1 mutant (middle), the 
basement membrane has not been invaded yet by the P6.p 4-cell stage. This delay is rescued 
by expression of VRK-1::GFP in the vulva cells from the vrk-1 promoter (right; arrowheads). 
Scale bar, 5µm. (B) The vrk-1 mutant at L4 stage does not have a uterine lumen nor does it 
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form an utse. Expression of VRK-1::GFP in the vulva cells rescues the uterine lumen (U) and 
utse (arrowheads). Scale bar, 10µm. 
 
Suppl. Fig. 4. VRK-1 is required for sex myoblast divisions. Control and vrk-1 mutant L3-L4 
larvae were staged based on Pn.p cell divisions and morphology. Sex myoblasts and their 
descendents were identified based on Pegl-15::GFP expression. Shown are myoblasts from 
either the left or the right side of the body. In the vrk-1 mutants sex myoblasts divided once 
while three rounds of division were observed in control animals. Scale bars, 10 µm. 
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Suppl. Table I. Strains generated for this study 
Strain Genotype 
BN3 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II 
BN10 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; let-60(n1046) IV. 
BN26 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; syls50[pkEx246 (Pcdh-3::GFP)] X 
BN37 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; syIs123[unc-119(+) Pfos-1::yfp::fos-1A] 
BN49 ayIs4 [Pegl-17::nls::gfp] I; vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II 
BN50 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; ccIs4810[Plmn-1::lmn-1::gfp] X 
BN53 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; vrIs13[Pvrk-1::vrk-1::gfp unc-119(+)] 
BN54 
vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; unc-119(ed4) syIs80[unc-119(+) 
pPGF11.13(Plin-11::nls::gfp)] III 
BN55 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; syIs[syEx920 (Pegl-43::nls::yfp)] 
BN72 
vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; syIs107[unc-119(+) Plin-3(Δpes-
10)::gfp]. 
BN76 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; vrIs15[Pvrk-1::vrk-1::gfp unc-119(+)] 
BN80 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; syls113[syEx563(Post-1::ost-1::gfp)] 
BN81 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; zhIs4[pTB10 Plip-1::nls::gfp] III 
BN82 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; ayIs2[Pegl-15::nls::gfp] IV 
BN118 fos-1(ar105)/dpy-11(e224) unc-42(e270) V; vrIs13[Pvrk-1::vrk-1::gfp unc-119(+)] 
BN121 vrk-1(ok1181)/mIn1[mIs14 dpy-10(e128)] II; qyls50[Pcdh-3::mCherry::moeABD] 
BN123 
bqEx123[Plin-31::vrk-1(s)::eat-2(i)::vrk-1(as); rol-6(d)]; ayIs4 I; rrf-3(pk1426) II; sid-
1(qt2) V 
BN124 
bqEx124[Plin-31::vrk-1(s)::eat-2(i)::vrk-1(as); rol-6(d)]; ayIs4 I; rrf-3(pk1426) II; sid-
1(qt2) V 
YL255 unc-119(ed3) III; vrIs13[Pvrk-1::vrk-1:gfp unc-119(+)] 
 2 
YL262 unc-119(ed3) III; vrIs15[Pvrk-1::vrk-1:gfp unc-119(+)] 
 
 
 
 
 
 
 
Suppl. Table II. Mutation of vrk-1 enhances LET-60 (Ras) gain-of-function phenotype. 
Genotype na Muvb (average ± S.D.c) 
vrk-1(ok1181) >100 0±0% 
let-60(n1046) 432 70.7±9.6% 
let-60(n1046); vrk-1(ok1181) 316 85.0±8.7%* 
 
Homozygous L4 and young adults were mounted on microscope slides and observed with a 
63x objective. aNumber of animals analyzed. bAverage Multivulva phenotype observed in four 
independent experiments at 20°C. cStandard deviation. *Statistically different from let-
60(n1046) (p<0.001 by Chi-square test). 
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Fig. 1. vrk-1 mutants show defects in germline, uterine and vulval development. (A) Sche-
matic representation of the vrk-1 gene. Purple: vrk-1 promoter used in this work; blue 
boxes: vrk-1 exons; light blue boxes: vrk-1 kinase domain; yellow box: BAB domain; 
shaded grey: 3’UTRs; red bar: region deleted in ok1181; dashed lines: mRNA splicing 
pattern. In ok1181 mRNA, exon 2 is spliced to exon 6. (B) Gonad arms of control and vrk-1  
mutant late L4 larvae outlined in white. The vrk-1 mutant gonad is smaller and contains 
abnormally enlarged cells (arrowheads). Boxed regions are shown at higher magnification 
to the left. (C) At late L4, the control larva has developed vulval (V) and uterine (U) lumens 
and uterine-seam cell connection (utse; arrowhead). The vrk-1 mutant has developed a 
vulval lumen, but the uterine lumen and the utse are missing. (D) Control adult animal 
shows a normally everted vulva whilst mutation of vrk-1 or RNAi-mediated depletion of 
VRK-1 specifically in vulva cells induces a protruding vulva (Pvl) phenotype (arrowheads). 
Scale bars, 10 μm.
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Fig. 2. Anchor cell invasion is impaired in vrk-1 mutants. (A) Vulval induction is normal in 
vrk-1 mutants as visualized by equal lin-3-driven expression of GFP in the AC of control 
and vrk-1 early L3 larvae. (B) In wild type early L3 stage, at the P6.p 4-cell stage, the AC 
has invaded the basement membrane, as can be seen by DIC and discontinuous 
SPARC::GFP signal. In the vrk-1 mutant, the AC has not invaded yet. (C) F-actin, visual-
ized by mCherry::moeABD expressed from the cdh-3 promoter, accumulates at the basal 
side of the AC in wild type L3 stage (arrow). In the vrk-1 mutant, foci of F-actin accumula-
tion are also observed apically (arrowhead). Scale bars, 5 μm
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Fig. 3. VRK-1 is expressed in the ventral nerve cord and vulva cells. (A) Expression of 
VRK-1::GFP from the vrk-1 promoter is observed in nuclei of ventral nerve cord cells 
(arrowheads), in all VPCs (1-cell stage) and is enriched in the descendants of the central 
P6.p (2-cell and 4-cell stages; brackets). At the onset of cell division, VRK-1::GFP relo-
cates to the nuclear rim (4-cell stage late). (B, C) The AC invasion delay (B) and the 
absence of a uterine lumen and utse (C) in the vrk-1 mutant (left) is rescued by expression 
of VRK-1::GFP (right). Arrowheads denote AC position (B) and utse (C); U denotes uterine 
lumen. Scale bars, 5 μm.
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Fig. 4. VRK-1 is required for specification of uterine precursor cells. (A) In control and vrk-1 
mutant animals, vulva cells have a normal nuclear appearance visualized by expression of 
LMN-1::GFP (arrowheads). In contrast, nuclei of uterine precursor cells (arrows) have an 
aberrant structure in the vrk-1 mutant. (B) In the control animal, 6 π cells on each side of 
the body are visualized by expression of GFP from the lin-11 promoter (arrowhead points 
to π cells on one side). In most vrk-1 mutants, no GFP expressing cells are observed. 
Scale bars, 5 μm.
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Fig. 5. VRK-1 stimulates FGF signaling. (A, B) The average fluorescent intensity of Pegl-
17::GFP in the descendents of P6.p (A) and of Pegl-15::GFP in the sex myoblasts at the 
1-cell stage (B) is reduced in vrk-1 mutants as compared to control animals (p<0.001, 
Student’s t-test). A.U. Arbitrary Units. (C) Expression of GFP driven by the lip-1 promoter in 
P5.p and P7.p, and to a lesser extent in P6.p, is similar in control and vrk-1 mutant 
animals. Scale bars, 5 μm.
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Fig. 6. Sumoylation regulates VRK-1 expression. (A) Expression of VRK-1::GFP in smo-
1(RNAi) larvae is highly up-regulated as compared to control RNAi larvae. At microscope 
settings for which fluorescent intensity reached saturation in the smo-1(RNAi) larvae, the 
VRK-1::GFP fluorescent signal is barely detectable in the control. Insert shows an image of 
the same control animal acquired using higher microscope sensitivity (0.3x magnification 
relative to other panels). (B) Expression of VRK-1::GFP in larvae depleted for UBA-2 is 
up-regulated as compared to control RNAi treatment. Scale bars, 5 μm. (C) Model of 
VRK-1’s role in vulval and uterine development. See Discussion for details. Pn.p, vulva 
precursor cells; VNC, ventral nerve cord cell; AC, anchor cell; π, uterine π cells; SM, sex 
myoblast.
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Suppl. Fig. 1. FOS-1 and its targets are expressed normally in vrk-1 mutants. (A-C) Expression of Pfos-
1a::FOS-1A::YFP (A), Pcdh-3::GFP (B) and Pegl-43::NLS::YFP (C) in the AC (arrowhead) is unaffected in vrk-1 
mutants as compared to control animals. (D) Similarly, expression of Pvrk-1::VRK-1::GFP is independent of 
fos-1. Scale bars,  5 μm. 
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Suppl. Fig. 2. Expression of Pvrk-1::VRK-1::GFP at the L4 larval stage in neurons and 
hypodermal cells in the head (left), tail (right) and ventral (down) area of the worm. Strong 
expression is observed in the developing vulva (insert). Scale bar, 40 μm. 
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Suppl. Fig. 3. vrk-1 mutant phenotypes are rescued by low expression of VRK-1::GFP from 
the integrated transgene vrIs15. (A) In control animals (left), the AC has invaded the base-
ment membrane by the P6.p 4-cell stage (arrowheads). In the vrk-1 mutant (middle), the 
basement membrane has not been invaded yet by the P6.p 4-cell stage. This delay is 
rescued by expression of VRK-1::GFP in the vulva cells from the vrk-1 promoter (right; 
arrowheads). Scale bar, 5μm. (B) The vrk-1 mutant at L4 stage does not have a uterine 
lumen nor does it form an utse. Expression of VRK-1::GFP in the vulva cells rescues the 
uterine lumen (U) and utse (arrowheads). Scale bar, 10μm.
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Suppl. Fig. 4. VRK-1 is required for sex myoblast divisions. Control and vrk-1 mutant L3-L4 
larvae were staged based on Pn.p cell divisions and morphology. Sex myoblasts and their 
descendents were identified based on Pegl-15::GFP expression. Shown are myoblasts 
from either the left or the right side of the body. In the vrk-1 mutants sex myoblasts divided 
once while three rounds of division were observed in control animals. Scale bars, 10 μm.
